1. Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF‐mutated melanoma and other advanced malignancies. Issue 3 (1st November 2018) Authors: Bhatty, Minny; Kato, Shumei; Piha‐Paul, Sarina A.; Naing, Aung; Subbiah, Vivek; Huang, Helen J.; Karp, Daniel D.; Tsimberidou, Apostolia M.; Zinner, Ralph G.; Hwu, Wen‐Jen; Javle, Milind; Patel, Sapna P.; Hu, Mimi I.; Varadhachary, Gauri R.; Conley, Anthony P.; Ramzanali, Nishma M.; Holley, Veron... Journal: Cancer Issue: Volume 125:Issue 3(2019) Page Start: 463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗